Phase 1 ALS Clinical Trials

27 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 120 of 27 trials

Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873
Recruiting
Phase 1Phase 2

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Amyotrophic Lateral Sclerosis(ALS)
Nura Bio80 enrolled6 locationsNCT07369076
Recruiting
Phase 1Phase 2

Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)

Toxicant ExposureFirefighterOccupational Exposure to Chemicals
University of California, San Francisco50 enrolled1 locationNCT07226440
Recruiting
Phase 1Phase 2

Intestinal Microbiome Transplant in ALS

Amyotrophic Lateral Sclerosis(ALS)
Duke University20 enrolled1 locationNCT07017946
Recruiting
Phase 1

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

ALS
Amylyx Pharmaceuticals Inc.48 enrolled14 locationsNCT06665165
Not Yet Recruiting
Phase 1

A study to assess safety, tolerability and pharmacokinetics of RTX-010/101/111 for participants with C9orf72-mediated Amyotrophic Lateral Sclerosis (ALS). Part 1C adults with C9orf72-mediated ALS only.

C9orf72-mediated Amyotrophic Lateral Sclerosis (ALS)
Repeat Therapeutics Pty Ltd16 enrolled1 locationACTRN12626000385347
Recruiting
Phase 1

A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

ALS
ITB-Med LLC48 enrolled3 locationsNCT06453668
Recruiting
Phase 1

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

ALS (Amyotrophic Lateral Sclerosis)
Eli Lilly and Company32 enrolled12 locationsNCT07100119
Recruiting
Phase 1

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

HIVHIV Infected Individuals
Institute of Hematology & Blood Diseases Hospital, China3 enrolled1 locationNCT06880380
Recruiting
Phase 1

Augmenting Ankle Plantarflexor Function in Cerebral Palsy

Cerebral Palsy
Northern Arizona University36 enrolled1 locationNCT05154253
Recruiting
Phase 1Phase 2

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

Amyotrophic Lateral Sclerosis(ALS)Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals42 enrolled16 locationsNCT06351592
Recruiting
Phase 1

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

ALS (Amyotrophic Lateral Sclerosis)
Celosia Therapeutics Pty Ltd15 enrolled1 locationNCT07401121
Recruiting
Phase 1

Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

EfficacySafetySpinal Cord Injury+4 more
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.12 enrolled1 locationNCT06976229
Recruiting
Phase 1

The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis(ALS)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.12 enrolled1 locationNCT07118319
Recruiting
Phase 1

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis(ALS)
Novabio Therapeutics12 enrolled1 locationNCT06671236
Recruiting
Phase 1

Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral SclerosisALS
Sunnybrook Health Sciences Centre6 enrolled1 locationNCT07193953
Recruiting
Phase 1Phase 2

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Bell Palsy
October 6 University90 enrolled1 locationNCT05821075
Recruiting
Phase 1

Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy

Genetic PredispositionDystoniaPediatric Disorder+5 more
Children's Mercy Hospital Kansas City40 enrolled1 locationNCT06554288
Recruiting
Phase 1

Effects of Peripheral Magnetic Stimulation on Cortical Excitability in Healthy Individuals

Healthy Individuals
Universidade Federal de Pernambuco18 enrolled1 locationNCT07025759
Recruiting
Phase 1

Effects of Trans-spinal Magnetic Stimulation on Cortical Excitability in Healthy Individuals

Healthy Individuals
Universidade Federal de Pernambuco18 enrolled1 locationNCT07026760